Examining MRI Features to Improve Prostate Cancer Diagnosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between MRI image characteristics and the diagnosis, pathology, and prognosis of prostate lesions in patients. It focuses on men with elevated prostate-specific antigen (PSA) levels or abnormal digital rectal examinations, utilizing advanced multiparametric MRI techniques to enhance the accuracy of prostate cancer detection. By analyzing MRI data, the study seeks to reduce unnecessary biopsies and improve patient outcomes. Participants will be recruited from Tongji Hospital in Wuhan, China.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients with abnormal prostate-specific antigen (PSA) elevated (\>4.0 ng/ml) or abnormal digital rectal examination (DRE) or suspicious lesions found by prostate ultrasound, CT or MRI in the hospital
2. Age/Gender: Adult male
3. Patients who voluntarily participate in clinical trials and sign a written informed consent form for subjects

Exclusion Criteria:

1. Patients with pacemakers, unknown materials, metal implants in the body, neurostimulators, and claustrophobia
2. Patients who underwent biopsy, local ablation, prostate surgery, or endocrine therapy, chemotherapy, radiotherapy and other anti-tumor treatments before examination

Where it's running

• Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
  Wuhan, Hubei, China Recruiting

Study contacts

• Study coordinator: Zhen Li
• Email: zhenli@hust.edu.cn
• Phone: 02783663543

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI analysis of ECGs to detect structural heart disease

  This project will test whether AI can read traditional and wearable ECGs to find undiagnosed valve disease, pulmonary hypertension, and heart failure in adults.

  Recruiting at 6 sites Imperial College London · Bristol and 5 other locations · NCT07057466

• Understanding NK Cell Function in Prostate Cancer Across Races

  This study tests whether natural killer (NK) cells behave differently in prostate cancer patients of diverse racial backgrounds by analyzing blood and tissue samples.

  Recruiting Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota · NCT07910019

• MRI or CT planning to guide high-dose-rate prostate brachytherapy

  This trial tests whether adding an MRI to CT-based treatment planning for HDR prostate brachytherapy changes urinary side effects in men with localized prostate cancer.

  Recruiting at 3 sites Emory University · Atlanta, Georgia and 2 other locations · NCT07859722

• Targeted Early Detection for Men at High Genetic Risk for Prostate Cancer

  This study tests urinary biomarkers and PSA to see if they can improve early detection for men with a strong family or genetic risk for prostate cancer.

  Recruiting University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT07645391

• 12-week ETAS® supplement for thinking, mood, sleep, and brain health in older adults

  This 12-week test will see if taking 1500 mg ETAS® daily helps thinking, mood, sleep, and brain scan measures in healthy adults aged 60–80 with mild cognitive complaints.

  Recruiting University of Reading · Reading, Berkshire · NCT07550140

• Urine and MRI approach to find aggressive prostate cancer early

  This study tests whether a urine test called MPS2, paired with MRI, can better detect aggressive prostate cancer in men 50–75 at risk, possibly reducing unnecessary biopsies.

  Recruiting University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT07526545

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.